RenaMed gets $2.3 million loan

By Elaine Rigoli

Tampa, Fla., June 19 - RenaMed Biologics, Inc. has received a $2.3 million loan from the Commonwealth of Massachusetts' emerging technology fund to implement commercial manufacturing operations in its newly leased facility in Westborough, Mass.

The company said it is expected to relocate to the Westborough facility, which will serve as its headquarters and commercial manufacturing facility for its renal bio-replacement therapy for acute renal failure, in the latter half of 2006.

RenaMed, located in Lincoln, R.I., is a clinical-stage company focused on the development of bio-replacement therapies for critical disease states involving severely compromised kidney function.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.